Strength Seen in ArQule (ARQL): Stock Soars 19.4% – Tale of the Tape

February 27, 2015 Technicals 0

Zacks

ArQule Inc. (ARQL) was a big mover last session with its shares rising over 19% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has gained nearly 73% in the past one-month time frame.

This clinical-stage biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.

ArQule currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Investors interested in the Med-drugs industry may consider Lannett Company, Inc. (LCI) that sports a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research

Be the first to comment

Leave a Reply